Author: Belief Biomed

Posted Date:

March 23, 2026

Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients

Belief Biomed

March 23, 2026
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China’s first hemophilia B gene therapy, was officially approved in Macao, China

Belief Biomed

March 19, 2026